CRISPR CAS9 2015: An interview with Dr Ping Zhang of Oxford University

Contributor:Chanice Henry
Posted: 02/09/2016
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Pharma IQ speaks to Dr Ping Zhang of Oxford University about the market behind gene editing technique CRISPR CAS9.

Have Your Say

Rate this feature and give us your feedback in the comments section below

Chan
Contributor: Chanice Henry